PTPRC and aneurysm: The mRNA levels of the common lymphocyte marker CD45 (Figure 5A, p = 0.63) and the monocyte/macrophage marker F4/80 (Figure 5B, p = 0.44) were not affected in the CAG treated aneurysms.